Yibo Quan

3PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 25, 2024
Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer.

Qingqing Luo, Yibo Quan, Wei Liu

|Aug 19, 2023
Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer.

Yibo Quan, Jie He, Qi Zou

|Feb 02, 2023
Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates.

Fang Wei, Yuling Su, Yibo Quan

Pageof 1

Frequent Collaborators

2 joint publications

Jie He

1 joint publications

Fang Wei

1 joint publications

Yuling Su

1 joint publications

Xiaojia Li